SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-23-000069
Filing Date
2023-09-26
Accepted
2023-09-26 16:41:12
Documents
1
Period of Report
2023-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5795
  Complete submission text file 0000886163-23-000069.txt   7240
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BOULEVARD SUITE 110 SAN DIEGO CA 92121
Business Address
Zimmermann Martine (Reporting) CIK: 0001994049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 231280913